[Antiepileptic drugs]

Rev Neurol. 2018 Jun 5;66(s02):S21-S25.
[Article in Spanish]

Abstract

We report the most notable pharmacokinetic and pharmacodynamic characteristics of the antiepileptic drugs commercialised in the last four years (eslicarbazepine acetate, brivaracetam and perampanel). Their efficacy and safety are analysed in open-label clinical trials, which are the ones that reproduce their use in everyday life, without the rigid protocols used in clinical trials.

Title: Farmacos antiepilepticos.

Se refieren las caracteristicas farmacocineticas y farmacodinamicas mas destacadas de los farmacos antiepilepticos comercializados en los cuatro ultimos años (acetato de eslicarbacepina, brivaracetam y perampanel). Se analiza su eficacia y tolerabilidad en estudios clinicos abiertos, que son los que reproducen su utilizacion en la vida diaria, sin los protocolos rigidos de los ensayos clinicos.

MeSH terms

  • Anticonvulsants / pharmacokinetics
  • Anticonvulsants / pharmacology*
  • Anticonvulsants / therapeutic use
  • Dibenzazepines / pharmacokinetics
  • Dibenzazepines / pharmacology*
  • Dibenzazepines / therapeutic use
  • Epilepsy / drug therapy
  • Humans
  • Nitriles
  • Pyridones / pharmacokinetics*
  • Pyridones / pharmacology
  • Pyridones / therapeutic use
  • Pyrrolidinones / pharmacokinetics*
  • Pyrrolidinones / pharmacology
  • Pyrrolidinones / therapeutic use

Substances

  • Anticonvulsants
  • Dibenzazepines
  • Nitriles
  • Pyridones
  • Pyrrolidinones
  • eslicarbazepine acetate
  • perampanel
  • brivaracetam